Morphological characteristics of primary diffuse large B-cell lymphoma of the central nervous system.
DOI:
https://doi.org/10.26641/1997-9665.2016.3.330-335Keywords:
primary CNS diffuse large B-cell lymphoma, brain tumor, proliferative activity, immunohistochemistryAbstract
Background. Primary central nervous system lymphoma is aggressive tumors with a poor prognosis, morphologically mostly diffuse large B-cell lymphoma (95%), which are included to separate nosological form - primary central nervous system diffuse large B-cell lymphoma. In recent decades, it is known these tumors have increasing incidence rate. Objective. Here we were determining the histological and immunohistochemical features of primary central nervous system diffuse large B-cell lymphoma for improving the morphologic diagnostics of this tumors type and developing predictive and prognostic factors. Methods. The study included 10 cases of primary central nervous system diffuse large B-cell lymphoma with tissue material received with biopsy or operation. The wide range of imunohistochemical stains (Ki-67, CD3, CD10, CD20, CD30, CD79α, BCL2, BCL6, GFAP) was used for detection of morphological characteristics in all cases. Results. We observed histological features of diffuse large B-cell lymphoma (diffuse or perivascular growth pattern of large round cells with frequently mitotic figures, apoptotic bodies and necrotic areas). In all cases we revealed CD20+ and CD79α+ (markers of B-lymphocytic differentiation) tumor cells. Expression of BCL6 and BCL2 was present in 80 and 60 percents of cases respectively. In addition some cases show CD30 or/and CD10 – immunoreactivity. Range of proliferative activity (Ki-67) was from 52 to 94%. Conclusion. The histological and immunohistochemical methods are useful for diagnosis of diffuse large B-cell lymphoma in tissues received with biopsy or brain resection. The typical features of diffuse large B-cell lymphoma are credible for diagnosis with using immunohistochemical status of neoplastic cells (CD20+, CD79α+, CD10 –, CD30–, BCL6+, BCL2+). The level of Ki-67 expression has potential important prognostic value due to its variability.
References
- Swerdllow SH, Campo E, Harris NL. WHO classification of tumours of haematopoietic and lymphoid tissues. France: IARC Press, 2008; 2008 Sep 20. ISBN 9789283224310
- Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. American Journal of Neuroradiology. 2011 Jun 1;32(6):984-92. doi: 10.3174/ajnr.A2171.
- Olson JE, Janney CA, Rao RD, Cerhan JR, Kurtin PJ, Schiff D, Kaplan RS, O'Neill BP. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma. Cancer. 2002 Oct 1;95(7):1504-10. doi: 10.1002/cncr.10851
- Giannini C, Dogan A, Salomão DR. CNS lymphoma. Journal of Neuropathology & Experimental Neurology. 2014 Jun 1;73(6):478-94. doi: 10.1097/NEN.0000000000000076.
- Bhagavathi S, Wilson JD. Primary central nervous system lymphoma. Archives of pathology & laboratory medicine. 2008 Nov;132(11):1830-4. doi: 10.1043/1543-2165-132.11.1830.
- Lister A, Abrey LE, Sandlund JT. Central nervous system lymphoma. ASH Education Program Book. 2002 Jan 1;2002(1):283-96. doi:10.1182/asheducation-2002.1.283
- Ferreri AJ. How I treat primary CNS lymphoma. Blood. 2011 Jul 21;118(3):510-22. doi:10.1182/blood-2011-03-321349
- Marturano E, Ferreri AJ. V. Primary CNS lymphoma in immunocompetent patients. Annals of Oncology. 2011 Jun 1;22(suppl 4):iv41-3. doi: 10.1093/annonc/mdr171
- Gerstner ER, Batchelor TT. Primary Central Nervous System Lymphoma. Archives of Neurology. 2010 Mar 1;67(3):291-7. doi: 10.1001/archneurol.2010.3.
- Taniguchi E. Primary lymphoma of the central nervous system: A clinicopathologic study. Brain tumor pathology. 2001 Sep 1;18(2):101-8. doi:10.1007/BF02479422
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Morphologia

This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world.
The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.
